Literature DB >> 34036259

CREATE: A New Data Resource to Support Cardiac Precision Health.

Seungwon Lee1,2,3,4, Bing Li1,3, Elliot A Martin1,3, Adam G D'Souza1,3, Jason Jiang1,3, Chelsea Doktorchik1,2, Danielle A Southern1,2, Joon Lee1,2,4,5, Natalie Wiebe1,2, Hude Quan1,2, Cathy A Eastwood1,2.   

Abstract

BACKGROUND: The initiatives of precision medicine and learning health systems require databases with rich and accurately captured data on patient characteristics. We introduce the Clinical Registry, AdminisTrative Data and Electronic Medical Records (CREATE) database, which includes linked data from 4 population databases: Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH; a national clinical registry), Sunrise Clinical Manager (SCM) electronic medical record (city-wide), the Discharge Abstract Database (DAD), and the National Ambulatory Care Reporting System (NACRS). The intent of this work is to introduce a cardiovascular-specific database for pursuing precision health activities using big data analytics.
METHODS: We used deterministic data linkage to link SCM electronic medical record data to APPROACH clinical registry data using patient identifier variables. The APPROACH-SCM data set was subsequently linked to DAD and NACRS to obtain inpatient and outpatient cohort data. We further validated the quality of the linkage, where applicable, in these databases by comparing against the Alberta Health Insurance Care Plan registry database.
RESULTS: We achieved 99.96% linkage across these 4 databases. Currently, there are 30,984 patients with 35,753 catheterizations in the CREATE database. The inpatient cohort contained 65.75% (20,373/30,984) of the patient sample, whereas the outpatient cohort contained 29.78% (9226/30,984). The infrastructure and the process to update and expand the database has been established.
CONCLUSIONS: CREATE is intended to serve as a database for supporting big data analytics activities surrounding cardiac precision health. The CREATE database will be managed by the Centre for Health Informatics at the University of Calgary, and housed in a secure high-performance computing environment.
© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 34036259      PMCID: PMC8134941          DOI: 10.1016/j.cjco.2020.12.019

Source DB:  PubMed          Journal:  CJC Open        ISSN: 2589-790X


Precision medicine, as part of a learning health care system, is an emerging medical framework proposing that medical decisions and treatments should be tailored to each individual patient, choosing optimal interventions while minimizing resource utilization. Ideally, learning health care systems should have the ability to leverage the massive amounts of patient data stored in electronic medical records (EMRs), to pick the optimal care pathway for a given patient. However, this has yet to come to fruition because of difficulties associated with processing EMR data, especially in the near real-time manner required for clinical decision support. For example, without some form of high-throughput automated phenotyping of patient characteristics, it is challenging to group similar patients in real time to predict the optimal care pathway for an individual. To achieve this aim, comorbidities and disease characteristics data must be captured to pinpoint the effects and outcomes associated with particular therapies. Current population-based administrative health databases lack sufficient sociodemographic (eg, income and education level) and clinical details (eg, disease stage, severity, and treatment), making it difficult to tailor individualized treatments and prevention strategies to each patient. For example, the popular Charlson comorbidity scores used in coded administrative databases do not allow consideration of disease stages. Additionally, coded data are not abstracted until after inpatient visits, making them unavailable for real-time clinical decision-making in Canada. EMR systems collect and digitize patient health information in real time, expediting clinical decision-making for individual patients to improve their quality of care. In Canada, EMRs are gradually being adopted, and are creating repositories of timely and comprehensive clinical information. Leveraging EMR data is crucial for achieving translational research in cardiovascular sciences,, and for cardiovascular precision health., EMR data enable point-of-care clinical decision support, patient safety alerts, and cardiovascular risk estimations.5, 6, 7 Numerous EMR-based research databases have been established internationally, often by linking databases. Examples include the Clinical Disease Research Using Linked Bespoke Studies and Electronic Health Records (CALIBER) database from the United Kingdom, which links the Clinical Practice Research Datalink (CPRD), Hospital Episode Statistics (HES), and Myocardial Ischemia National Audit Project (MINAP) data, and the Electronic Medical Records and Genomics (eMERGE) network data in the United States, which links inpatient EMR data to genomics data. These databases have been used in numerous cardiovascular studies.10, 11, 12, 13, 14, 15 Existing stand-alone Canadian databases contain restricted details of physician claims, laboratory tests, medications, specialist consultation letters, and hospital discharges (eg, the Canadian Primary Care Sentinel Surveillance Network [CPCSSN] and Electronic Medical Record Administrative Data Linked Database [EMRALD])., Clinical cardiovascular registries have informed numerous studies to date, but rely on data collected on patients’ baseline characteristics, previous treatments, and outcomes. Detailed clinical outcome data from EMRs are consequently needed for developing enhanced individualized risk predictions and scoring systems that can advance translational research in cardiovascular sciences. EMR and clinical registry data are often held separately, and bringing them together would provide valuable information on disease occurrence and progression. The intent of this work is to introduce a cardiovascular disease-specific database called Clinical Registry, AdminisTrative Data and Electronic Medical Records (CREATE) and discuss potential applications for precision medicine and population public health.

Methods

This section describes the data sources and linkage process behind the CREATE database.

Data sources

EMR: Sunrise Clinical Manager

Sunrise Clinical Manager (SCM) EMR data are collected as part of routine health care practice, and the data have so far not been widely used for research purposes. SCM provides patient-level clinical information including medical and nursing orders, medication records, clinical documentation, and diagnostic imaging and lab results. SCM also includes key demographic and visit information, as well as historical chart data. SCM supports inpatient locations, outpatient clinics, and emergency departments. Details of SCM data elements are described in a previous publication. The data elements of SCM included in CREATE are listed in Supplemental Table S1.

Clinical registry: APPROACH

The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) project has prospectively collected and assembled 3 sequential cohorts comprising approximately 170,000 patients between 1998 and 2017 in Alberta: (1) patients who underwent cardiac catheterization; (2) patients who received percutaneous coronary intervention (PCI); and (3) patients who received coronary artery bypass grafting (CABG). The cardiac catheterization cohort is the largest. A subset of this cohort consists of patients who later underwent PCI, or CABG. This cohort includes inpatients and outpatients. Extensive details of APPROACH data can be found in other journal articles, and from the APPROACH website, www.APPROACH.org. A condensed list of data elements incorporated in CREATE is provided in Supplemental Table S2.

Administrative data: DAD and NACRS

The Discharge Abstract Database (DAD) captures administrative, clinical, and demographic information on inpatients at the time of discharge., The National Ambulatory Care Reporting System (NACRS) captures all hospital-based and community-based ambulatory care data including day surgery, outpatient, urgent care, and emergency department visits. The content and quality of these 2 national administrative databases are managed by the Canadian Institute for Health Information. Diagnoses are coded using the International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada (ICD-10-CA), and procedures and interventions using Canadian Classification of Health Interventions codes. In this work, DAD served as an inpatient indicator database and NACRS served as an outpatient indicator database. The list of data elements used for CREATE is provided in Supplemental Table S3.

Study population

We selected all cardiac catheterization patients in Calgary between April 1, 2011 and March 31, 2017. The patient data were captured from the APPROACH clinical registry, in which clinical information on Albertans with diagnostic cardiac catheterization and/or revascularization procedures and patients admitted to cardiac wards is collected. The total size of our study population was determined by the operational history of the SCM EMR, and by cardiac catheterization practices in Alberta. The SCM EMR system has been maintained and operated in the Calgary zone of Alberta Health Services (AHS), the single health authority in the province of Alberta, since 2006. It has undergone multiple design changes before full implementation in 2011. There are 3 acute care hospitals in Alberta that provide cardiac catheterization: Foothills Medical Centre in Calgary, and the Royal Alexandria and University of Alberta Hospitals in Edmonton. Calgary accounts for 46.5% of the catheterizations in Alberta. SCM does not capture data from the Edmonton hospitals.

Data exploration and data cleaning

The accuracy of sex and date of birth variables in SCM and APPROACH, used as linkage variables for these 2 data sets, was checked by comparing against the Alberta Health Insurance Care Plan (Registry) data, which stores information about all people who have or have previously been registered for Alberta health insurance coverage. The SCM database contains more than 3000 tables, and approximately 700 tables contain pertinent patient information. The complex data structure was understood by: (1) making use of an assembled internal SCM dictionary; (2) consulting data users who were familiar with SCM EMR data; and (3) gaining access to the production copy of SCM EMRs to track the flow of data between the front end and the back end, and to develop the queries used to pull and link the data. We traced the flow of SCM data from when it was entered by clinicians in the front end of the SCM EMR system (the user interface), to when it arrived in the back end (the database tables). The front end and back end of SCM are described in further detail in a previous publication. AHS analysts created example records from the front end of the system and tracked the same document to the production copy of the back end data. This process allowed time stamps to be correctly tracked and ensure that final versions of the free-text documentation and other structured elements would be pulled. Structured Query Language, Python 3.8.5 (Python Software Foundation, Beaverton, OR), and SAS 9.4 (SAS Institute Inc, Cary, NC) were used for these processes.

Data linkage

Linkage of SCM EMR and APPROACH Clinical Registry

The Calgary APPROACH data were first linked with the SCM client table on the basis of the patients’ personal health number (PHN), last name, first name, sex, and date of birth.

Linkage of SCM EMR and APPROACH Clinical Registry to Administrative Databases (NACRS and DAD)

We linked the SCM EMR and APPROACH Clinical Registry (SCM-APPROACH) with administrative databases. For DAD, which captures data on inpatient catheterizations, we required the following criteria: (1) a match on the patient’s PHN; and (2) the catheterization date had to fall between the hospital admission date minus 3 days, and discharge date plus 3 days, with the 3-day tolerance chosen to account for observed discrepancies in time stamps between the 2 sources. In SCM-NACRS, which captures data on outpatient catheterizations, the service end date is not a mandatory data requirement for outpatient clinic visits. However, the service start date (visit date) was mandatory and was 100% complete. Therefore, we linked APPROACH and NACRS using the following criteria: (1) a match on the patient’s PHN; and (2) the catheterization date falling between 3 days before and 3 days after the visit date. Figure 1 shows the CREATE cohort selection and data linkage process.
Figure 1

Clinical REgistry, AdminisTrative Data and Electronic Medical Records (CREATE) cohort selection and linkage process. The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) clinical registry was linked to the Sunrise Clinical Manager (SCM) electronic medical record (EMR) using patient details. This linked database (SCM-APPROACH) was subsequently linked to administrative databases (Discharge Abstract Database [DAD]/National Ambulatory Care Reporting System [NACRS]) using catheterization episodes. Cylinders represent relational databases and rectangles represent flat tables.

Clinical REgistry, AdminisTrative Data and Electronic Medical Records (CREATE) cohort selection and linkage process. The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) clinical registry was linked to the Sunrise Clinical Manager (SCM) electronic medical record (EMR) using patient details. This linked database (SCM-APPROACH) was subsequently linked to administrative databases (Discharge Abstract Database [DAD]/National Ambulatory Care Reporting System [NACRS]) using catheterization episodes. Cylinders represent relational databases and rectangles represent flat tables.

Results

The Alberta-wide APPROACH cohort between 1998 and 2017 totaled approximately 170,000 patients who received catheterization. This sample size was reduced to 31,007 patients when the patient cohort was narrowed to those who received the procedure within acute care facilities in Calgary from 2011 to 2017.

Data exploration

Before linkage, we checked the quality of linkage variables by comparing against the registry. There were 268 patients who had inconsistencies on either sex or date of birth in the SCM and/or APPROACH compared with the registry. These records were updated with registry data.

Linkage of the SCM to APPROACH

Among the 31,007 patients who received a total of 35,784 catheterizations in Calgary acute care facilities and whose data were recorded in the APPROACH database, 30,994 (99.96%) were linked between APPROACH and the SCM EMR. Only 13 patients from APPROACH were not linked to the SCM EMR because 7 did not match on PHN (first level identifier) and 6 matched on PHN but did not match on the combination of last name, first name, sex, or date of birth. There were 35,768 catheterizations for those 30,994 patients.

Linkage of SCM-APPROACH to DAD and NACRS

The linkage rate using catheterization events was 99.96% (35,753/35,768) between SCM-APPROACH and DAD/NACRS. In the APPROACH registry, 24,603 catheterization records were successfully linked with DAD and 11,150 catheterization records with the NACRS database. Of the 15 catheterization records that were unlinked, 6 did not match on PHN, and 9 matched on PHN but the procedure date did not meet the criteria. The linkage steps are depicted in Figure 1.

Overview of the CREATE cohort

The major demographic and clinical characteristics of the CREATE cohort are summarized in Table 1. A total of 20,373 patients (65.7%) received inpatient catheterizations and 9226 (29.8%) patients received catheterizations in outpatient settings. Most patients from each cohort (90.1% of inpatients, and 95.9% of outpatients) had only 1 catheterization episode. Men accounted for 70% of each cohort. Mean and median ages were 65 years for both cohorts. A total of 1389 (5.0% of total cohort) patients had catheterization in inpatient and outpatient settings on different admission dates.
Table 1

Characteristics of inpatient and outpatient CREATE cohorts on index catheterization encounter in APPROACH

CharacteristicInpatient cohortOutpatient cohort
Total unique patients20,3739226
 1 Catheterization18,360 (90.1)8850 (95.9)
 2 Catheterizations1674 (8.2)356 (3.9)
 3 or more catheterizations339 (1.7)20 (0.2)
Male sex14,476 (71.1)6357 (68.9)
Median age (IQR), years64.1 (55.8 -73.2)65.7 (58.0-73.1)
Diagnoses and comorbidities
 Cerebral vascular disease1124 (5.5)576 (6.2)
 Congestive heart failure3052 (15.0)1143 (12.4)
 Chronic obstructive pulmonary disease3217 (15.8)1710 (18.5)
 Diabetes5573 (27.4)2826 (30.6)
 Hypertension13,803 (67.8)6783 (73.5)
 Hyperlipidemia12,250 (60.1)6427 (69.7)
 Liver disease409 (2.0)278 (3.0)
 Malignancy1039 (5.1)520 (5.6)
 Myocardial infarction2024 (9.9)882 (9.6)
 Peripheral vascular disease1438 (7.1)764 (8.3)
Procedures
 Previous PCI2306 (11.3)1134 (12.3)
 Previous CABG1,005 (4.9)500 (5.4)

Data are n or n (%)

APPROACH, Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease; CABG, coronary artery bypass grafting; IQR, interquartile range; PCI, percutaneous coronary intervention.

Characteristics of inpatient and outpatient CREATE cohorts on index catheterization encounter in APPROACH Data are n or n (%) APPROACH, Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease; CABG, coronary artery bypass grafting; IQR, interquartile range; PCI, percutaneous coronary intervention. Hypertension and hyperlipidemia were the most common comorbidities in both cohorts, experienced by more than 60% of patients. A total of 11.3% (n = 2306 patients) of the inpatients had previous PCI, and 4.9% (n = 1005) had previous CABG. Among outpatients, 12.3% (n = 1134 patients) and 5.4% (n = 500) had previous PCI and previous CABG, respectively.

Discussion

Building toward precision medicine

Integrating EMR data with other data modalities is crucial for achieving precision medicine initiatives and building a learning health system. Linking these 3 data sources led to the creation of a large catheterization cohort that has the potential to allow for big data analytics. Each of the 3 linked data modalities contain distinct clinically relevant information. We briefly recap some of the most salient elements from these data sets, and then describe 3 potential research applications illustrating the power of using them together for EMR data analytics.

Approach

Patients’ cardiovascular conditions and their comorbidities are documented in APPROACH, but not necessarily in the EMR when they undergo catheterization by clinicians., Furthermore, APPROACH might document comorbidity status more comprehensively than administrative data. Consequently, APPROACH data could serve as a reference standard for EMR analytics. For example, the data could be used for developing and validating EMR data-based phenotyping algorithms for accurately defining cardiovascular conditions. Using clinical registries such as APPROACH can save considerable human and financial resources compared with the traditional method of conducting manual chart reviews to establish a reference standard.

DAD/NACRS

International Classification of Diseases-coded administrative data are often used for defining cohorts and risk adjustment., The routinely collected data are widely available, but undercoded or miscoded for numerous conditions. DAD and NACRS are crucial for dividing the CREATE database into outpatient and inpatient cohorts, because EMR data associated with these admissions will vary and will affect future EMR data-based studies and their methodology protocols. These databases also provide insights on resource utilization and outcome data, and enable long-term follow-up for events that require hospitalization.

SCM

EMRs contain comprehensive accounts of patients’ medical conditions, including free-text narrative documents (eg, clinical notes and discharge summaries). However, these types of data are challenging for downstream analytics applications. Natural language processing, often in conjunction with machine learning or deep learning, are required to analyze EMRs.5, 6, 7 However, EMR data are messy to work with, and other data sources containing high-quality structured data elements are valuable for cohort identification and for informing study designs. Our high data linkage of 99.96% ensured that the Calgary catheterizations cohort was successfully created using the APPROACH, EMR, and administrative databases. Our high linkage rate is because of Alberta’s single-payer health insurance system and the existence of PHNs as a unique lifetime identifier. Our team was previously successful in conducting a linkage study between a provincewide surveillance system and an administrative database using similar methods. The CREATE database enables many different kinds of EMR-based analytical studies that support precision cardiac medicine. We discuss 3 potential research applications of the CREATE database.

Application 1: EMR phenotyping

The area of research that uses EMR data to develop comorbidity definitions is known as EMR phenotyping, and EMR-based phenotypes often show superior performance compared with traditional methods that use other data sources. For example, Nath et al. developed the EchoInfer application, which can extract clinical information from echocardiography reports housed in an EMR system. Xu et al. developed an EMR data-based congestive heart failure phenotyping algorithm, by applying natural language processing on discharge summaries and structured EMR data elements. EMR phenotyping development requires an initial reference standard (eg, comorbidity status from APPROACH). When EMR phenotypes with good validity are developed, they can be deployed on longitudinal EMR data to extract comorbidity progression over time. Such enhanced comorbidity identification can be integrated into existing clinical support processes and systems to enable individualized clinical decision-making. This can be achieved by enhancing existing risk scoring systems such as the LACE (Length of stay, Acuity of the admission, Comorbidity of the patient, and emergency department use in the duration of 6 months before admission) index and the Framingham Risk Score for improving patient outcomes and supporting learning health systems.,,

Application 2: developing individualized treatment approaches

A second potential application area is to develop individualized approaches to treatment using comprehensive longitudinal clinical data. Evidence from previous studies shows that EMR data can improve risk estimates. Kennedy et al. predicted the risk of cerebrovascular and cardiovascular death, and compared the Framingham Risk Score with regression methods using longitudinal clinical EMR data. The results indicated that longitudinal regression methods outperformed the Framingham score. Zhao et al. extracted aggregated longitudinal features from EMR data and showed improved cardiovascular event prediction. Panahiazar et al. used a hierarchical clustering algorithm to develop a heart failure therapy response medication recommendation plan on the basis of a patient similarity index developed using EMR data. Additionally, CREATE can support direct comparison of these methods with traditional risk adjustment methods that rely on International Classification of Diseases-coded data.

Application 3: Building synergistic human-artificial intelligence hybrid systems for clinical decision support

A third potential application is designing artificial intelligence (AI)-based algorithms that will work in tandem with human clinicians, leading to improved data-informed decision-making. AI technologies excel at detecting patterns in complex, high-dimensional data, but can only learn from the data that are recorded electronically. In contrast, human clinicians collect a wide array of qualitative data that might inform optimal treatment decisions. There is the potential for developing interactive human-AI processes that synergistically combine clinical knowledge and intuition with predictive AI, to develop systems and tools for informing personalized treatment decisions, thereby supporting the goals of precision medicine and precision public health. For example, it was recently shown that AI-assisted clinicians were better able to diagnose skin cancer than either AI or individual clinicians alone. Building machine learning prediction models on cardiac outcomes using cardiac-specific clinical data, guided by clinical knowledge from clinicians (ie, cardiologists), might allow development of similar clinical decision support tools. Access to databases that are rich in clinical information, such as CREATE, will be essential for such endeavours.

Additional data linkage and infrastructure

The CREATE database represents a major milestone in building an enriched cardiovascular disease-specific database. The CREATE database can be linked to additional databases, such as genomics data, and has the potential to bridge the gap between biological sciences and applied health sciences. Data extraction, storage, and management agreements with health authorities are in place for maintaining, updating, and expanding the databases to answer specific research questions. The CREATE database will be housed on the Medical Advanced Research Computing (MARC) cluster. MARC is a secure high-performance computing infrastructure, which is approved by AHS to store sensitive data (eg, SCM EMRs) at the University of Calgary. The University of Calgary has been designated as the Information Manager in collaboration with AHS for the CREATE database on this high-performance computing infrastructure. Having health system buy-in will be critical to turn CREATE into a real-time data set that supports a fully operational learning health system.

Limitations

This study has some limitations. First, highly restricted access was required by health system authorities under the terms of the information management agreement, because of the sensitive content and the difficulty of deidentifying unstructured data. As such, the CREATE database is not publicly available. We are presently exploring deidentification protocols, on the CREATE database to remedy this. Second, the CREATE database does not cover the entire population of cardiac patients in Calgary. This cohort is limited to patients who have undergone diagnostic coronary angiogram and revascularization procedures. The patients not covered and their outcomes have been previously studied., Finally, the outpatient cohort does not contain equally comprehensive documentation, laboratory results, and problem lists as the inpatient cohort. Primary care EMR data should ideally be linked, because patients are often referred to primary care physicians after cardiac procedures.

Conclusion

CREATE was established to pursue cardiac precision medicine activities and facilitate big EMR data analytics. Future research applications will focus on: (1) EMR phenotyping; (2) developing individualized clinical and treatment approaches; and (3) building AI-based assistive decision-making tools.
  42 in total

1.  Electronic health records-driven phenotyping: challenges, recent advances, and perspectives.

Authors:  Jyotishman Pathak; Abel N Kho; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2013-12       Impact factor: 4.497

2.  Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.

Authors:  Hude Quan; Bing Li; L Duncan Saunders; Gerry A Parsons; Carolyn I Nilsson; Arif Alibhai; William A Ghali
Journal:  Health Serv Res       Date:  2008-08       Impact factor: 3.402

3.  Capturing diagnosis-timing in ICD-coded hospital data: recommendations from the WHO ICD-11 topic advisory group on quality and safety.

Authors:  V Sundararajan; P S Romano; H Quan; B Burnand; S E Drösler; S Brien; H A Pincus; W A Ghali
Journal:  Int J Qual Health Care       Date:  2015-06-04       Impact factor: 2.038

4.  Using data linkage methodologies to augment healthcare-associated infection surveillance data.

Authors:  Seungwon Lee; Paul Ronksley; John Conly; Stephanie Garies; Hude Quan; Peter Faris; Bing Li; Elizabeth Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2019-07-29       Impact factor: 3.254

Review 5.  Practical use of the Framingham risk score in primary prevention: Canadian perspective.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2011-04       Impact factor: 3.275

6.  Human-computer collaboration for skin cancer recognition.

Authors:  Philipp Tschandl; Christoph Rinner; Zoe Apalla; Giuseppe Argenziano; Noel Codella; Allan Halpern; Monika Janda; Aimilios Lallas; Caterina Longo; Josep Malvehy; John Paoli; Susana Puig; Cliff Rosendahl; H Peter Soyer; Iris Zalaudek; Harald Kittler
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

7.  Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. On behalf of the APPROACH investigators.

Authors:  W A Ghali; M L Knudtson
Journal:  Can J Cardiol       Date:  2000-10       Impact factor: 5.223

8.  Characterizing types of readmission after acute coronary syndrome hospitalization: implications for quality reporting.

Authors:  Danielle A Southern; Jennifer Ngo; Billie-Jean Martin; P Diane Galbraith; Merril L Knudtson; William A Ghali; Matthew T James; Stephen B Wilton
Journal:  J Am Heart Assoc       Date:  2014-09-18       Impact factor: 5.501

9.  The HOSPITAL score and LACE index as predictors of 30 day readmission in a retrospective study at a university-affiliated community hospital.

Authors:  Robert Robinson; Tamer Hudali
Journal:  PeerJ       Date:  2017-03-29       Impact factor: 2.984

10.  Acute coronary syndrome patients admitted to a cardiology vs non-cardiology service: variations in treatment & outcome.

Authors:  Deirdre E O'Neill; Danielle A Southern; Colleen M Norris; Blair J O'Neill; Helen J Curran; Michelle M Graham
Journal:  BMC Health Serv Res       Date:  2017-05-16       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.